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Abstract. We report an organic-inorganic hybrid core-shell nanomaterial obtained by 
conjugation of an amphiphilic monomethoxy-poly(ethylene glycol)-b-poly(epsilon-
caprolactone) diblock copolymer to hydroxylated boron nitride nanotubes (BNNTs). 
The extent of copolymer grafting reached 64% w/w, an exceptionally high value.  The 
hybrid materials exhibit excellent physical stability in water and an outstanding loading 
capacity (31.3% w/w) for curcumin, a hydrophobic drug. Moroever, they present good 
compatibility with the Caco2 cell line, a model of intestinal epithelium. Our findings 
demonstrate the potential of multifunctional hybrid BNNTs to serve as a platform for  
complex amphiphilic nanoparticle architectures with improved features. 
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Core-shell nanostructures, have been investigated extensively for the encapsulation, 
delivery, and targeting of hydrophobic drugs. In this context, polymeric micelles have 
reached clinical trials in cancer therapy.1–4 However, a main disadvantage is their 
limited physical stability under extreme dilution in body fluids.5 Our recent efforts are 
focused on innovative approaches towards  the design and synthesis of amphiphilic 
nanomaterials that, on the one hand, are as effective as polymeric micelles in terms of 
hydrophobic drug encapsulation, and, on the other, display maximum physical stability 
and resistance against dilution. In the past, we employed nanodiamonds as particulate 
anchors for the conjugation of polymeric amphiphiles made of poly(ethylene glycol)-
b-poly(epsilon-caprolactone) (PEG-b-PCL).6 These core-anchored nanomaterials were 
very stable in suspension, encapsulated up to 17.5% w/w of the hydrophobic drug 
nitazoxanide and sustained its release in vitro by anomalous transport. This was a 
significant finding, since most strategies proposed to stabilize polymeric micelles tend 
to decrease their loading capacity and/or compromise the integrity and the activity of 
the encpasulated cargo.5,7 We are interested to explore the versatility of this approach 
and to extend it to inorganic nanomaterials with different nanostructures and 
morphoplogies.   
Boron nitride nanotubes (BNNTs), exceptionally strong and inert materials,8  were 
shown to be non-toxic as long as their length does not exceed a few microns.9 Pristine 
BNNTs are hydrophobic and do not disperse well in water, a fundamental drawback 
towards their utilization in biomedical applications. Their dispersibility in aqueous 
media is improved upon adsorption of water-soluble polymers,10,11 such as poly(L-
lysine)12, or by exposing BNNTs to ammonia plasma, which  increases the number of 
active N sites. Ammonia plasma is believed to generate a coordination bond through 
charge transfer from N to B, when the energy barrier is below 0.45 eV.13,14  A milder 
approach consists in treating BNNT dispersions in hydrophilic solvents with 
hydrophilic primary amines, such as glycine or aminoethanol that form a strong N—B 
charge transfer bond interaction.15,16 It is also possible to oxidize B with concentrated 
nitric acid to produce –OH moieties.17 These strategies paved the way to improve the 
physical stability of BNNT aqueous dispersions.13,17 Following a similar concept, 
Weng et al. reported on the synthesis of hydrophilic BNNTs by the thermal substitution 
of C atoms in graphitic carbon nitrides with boric acid, forming BN(OH) with high 
hydroxylation degree.18 These materials can incorporate large payloads (~300 wt%) of 
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the water-soluble anti-cancer drug doxorubicin for stronger activity in vitro. However, 
these chemical modifications did not improve the encapsulation of hydrophobic 
molecules, which represent >70% of the drugs on the market and the new chemical 
entities under investigation. Recently, Niskanen et al. demonstrated that the inner 
channel of glycine-coated BNNTs can be loaded efficiently with hydrophobic drugs 
and serve as intracellular nano-delivery agents.16 To the best of our knowledge, this 
represents the first report ever on the encapsulation of a hydrophobic cargo within 
BNNTs. Rod-shaped nanoparticles are known to be internalized efficiently by cells via 
active uptake.19,20 These properties make BNNTs appealing candidates for 
encapsulation and delivery applications.  
BNNTs display extremely high surface-to-mass ratio21 which, a priori, enables higher 
weight ratio of surface modification than other very dense ceramic nanomaterials 
currently under investigation (e.g., nanodiamonds). We hypothesized that BNNTs 
oxidized on the surface to display reactive –OH moieties could serve as anchors for the 
conjugation of monofunctional amphiphilic diblocks, leading to hybrid core-shell 
amphiphiles with superior physical stability and encapsulation features than regular 
polymeric micelles (Figure 1A). We set up to confirm the valididy of this strategy using 
a monofunctional PEG-b-PCL diblock copolymer as amphiphilic coating.  The 
successful outcome of this study, that to the best of our knowledge represents the report 
on the surface modification of BNNTs by conjugation of an amphiphilic copolymer, is 
reported here. The PEG-b-PCL copolymer molecular weight of 7800 g/mol (calculated 
by 1H NMR) and hydrophilic-lipophilic balance of ≅ 12.8 was synthesized  by ring-
opening polymerization of ε-caprolactone (CL), using the terminal –OH group of a 
capped PEG (PEG, molecular weight of 5000 g/mol) as initiator in the presence of 
tin(II) 2-ethylhexanoate (SnOct) as catalyst (Figure 1B).22 The Mn of the PCL block 
and of PEG-b-PCL was determined by 1H NMR (in chloroform-d) using the areas of 
the signal at 3.3 ppm, due to the terminal methyl protons of PEG,  and at 2.25 ppm 
attributed to the methylene protons of PCL (Figure S1). Gel permeation 
chromatography (GPC) of the copolymer presented a single monomodal elution band 
of low polydispersity (Đ = 1.14) (Figure S2, Table S1). The diblock was reacted with 
maleic anhydride (MA) to form a terminal carboxylic acid group (Figure 1B). The 
successful modification was confirmed by 1H NMR spectroscopy (Figure S3).  
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Figure 1. Synthesis of BNNT-based amphiphilic core-shell nanomaterials. (A) 
Schematic representation of BNNs / amphiphilic diblock copolymer conjugates. (B) 
Synthesis of PEG-b-PCL by ring-opening polymerization of ε-caprolactone (CL) with 
monomethoxy-poly(ethylene glycol) (PEG) and subsequent reactions with maleic 
anhydride and thionyl chloride yielding the desired acyl chloride-modified derivatives 
and (C) conjugation of the reactive diblock copolymer to the oxidized surface of 
BNNTs 
BNNTs 
PEG-b-PCL 
A 
C 
B 
CUR 
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Subsequently, the carboxylic acid was converted into the reactive acyl chloride with 
thionyl chloride (SOCl2) in toluene (Figure 1B) that was conjugated to the -OH groups 
generated on the surface of BNNTs by oxidation with concentrated nitric acid 
immediately before conjugation (Figure 1C). The recoved BNNT-PCL-b-PEGs were 
thoroughly washed to remove any physically bound copolymer by dispersing in 
acetone, centrifuging and removing unconjugated polymer in the supernatant. This 
procedure was repeated several times. GPC analysis of all the PEG-b-PCL diblock 
intermediate products confirmed its chemical stability during the modification stages 
(Table S1). Thermogravimetric analysis (TGA) of glycine functionalized BNNTs after 
the cutting process16 and before treatment nitric acid showed a weight loss of 6% w/w 
at 370°C (Figure 2A), most probably related to the degradation of glycine residues.23  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Characterization of the BNNT-PCL-b-PEG hybrid core-shell materials. 
(A,B) Thermograms of cut BNNTs prior to chemical modification and after PCL-b-
PEG conjugation  (BNNT-PCL-b-PEG), PEG-b-PCL and PEG; (B) FTIR of BNNTs, 
chemically-modified BNNT-PCL-b-PEG and the physical adsorption of PEG-b-PCL 
on BNNTs surface. (C) TEM image of BNNT-PCL-b-PEG. Insets show details of 
BNNTs at higher magnification. Arrows in C point out the thick polymeric layer 
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conjugated to the surface of the nanotubes, while the lines delimit the boundaries of the 
inner channel. (D) Size distribution (Dh) expressed in nm of BNNT-OH (patterned bars) 
and BNNT-PCL-b-PEG (filled bars) incubated over one week, as measured by DLS. 
 
TGA analysis of hybrid BNNT-PCL-b-PEG showed a weight loss of 64% w/w over a 
wide temperature range (~200-585°C) corresponding to the degradation of both PEG 
and PCL (Figures 2A,S4). This high conjugation extent (based on wt%) can be 
probably attributed to the high surface  density of -OH groups generated on the surface 
of the nanotubes upon oxidation and the very low tap density of BNNTs of 
approximately 0.25 g/cm3.24 The morphology and the nanostructure of the BNNTs 
before and after conjugation of PEG-b-PCL were visualized by transmission electron 
microscopy (TEM). Unmodified BNNTs present a smooth outer surface.  The inner 
channel along the longitudinal axis is clearly observed (Figure S5A). PEG-b-PCL-
modified BNNTs present a thick homogeneous outer layer that is consistent with the 
efficient surface conjugation (Figure 2C). The inner channel is apparent, inspite of the 
polymeric shell. It is worth stressing that the oxidation stage did not alter the structure 
of the nanotubes. TEM analysis was also used to measure the average length of the 
nanotubes after the cutting process and the nitric acid treatment. The average length 
was 2.06 ± 0.6 µm (n = 188) (Figure S5B). After the conjugation of the copolymer, the 
length did not change (data not shown). By DLS, the length of pristine BNNTs was 
3.56 ± 0.10 µm (Dh of 773 ± 86 nm), while the average length of BNNT-PCL-b-PEG 
was 3.59 ± 0.07 µm (Dh of 781 ± 27 nm), confirming that the conjugation of the 
copolymer did not alter the size of the BNNTs. The procedure for converting Dh (that 
it is not the actual diameter of nanotube but the average obtained by DLS) to length can 
be used in case the nanotubes are well dispersed and it is presented as supporting 
information.  
The dispersion stability of the BNNTs before and after the modification was monitored 
by DLS over one week, at 25°C. At day 0, BNNT-OH showed Dh of 773 ± 86 nm 
(represents a length of 3.50 µm) (Figure 2D) and after one day, a bimodal size pattern 
with a major population with Dh of 4.4 ± 0.4 m (5.7-fold increase in Dh) and a minor 
one of 467 ± 237 nm (represents a length of 1.83 µm). These results indicated that, 
regardless of the presence of hydrophilic –OH moieties on the surface and the non-ionic 
surfactant Pluronic® F127 (a linear poly(ethylene oxide)-b-poly(propylene oxide)-b-
poly(ethyelene oxide) copolymer) used to disperse them, most of the BNNTs 
8 
 
aggregated even after 1 day; the surfactant modifies the nanotube surface by adsorption 
through the central hydrophobic poly(propylene oxide) block. The minor population of 
smaller size would suggest the presence of shorter nanotubes that were more 
successfully dispersed by the surfactant. However, at day 7, the instrument was not 
capable of measuring the Dh of BNNT-OH due to Dh values >10 m, being in 
agreement with a massive aggregation. Remarkably, BNNT-PCL-b-PEG were very 
stable for at least one week owing to the steric stabilizing effect of the outer PEG layer 
of the conjugated copolymer (Figure 2D). The statistically significant decrease in Dh 
between days 0 and 1 (P <0.01) indicated a time-dependent homogenization effect of 
the hydrophilic PEG shell due to a more complete dispersion of the nanotubes.25 Then, 
the size change was not statistically significant.    
The use of inorganic nanotubes by parenteral routes (e.g., intravenous) has been 
proposed, though they rise serious safety concerns.26–28 Some researchers observed that 
oral administration of carbon nanotubes, even at very high doses (1,000 mg/kg 
bodyweight), do not show toxicity.26 Moreover, nanotubes could be entrapped by 
mucus and thus perform as mucoadhesive nanocarriers.29 Thus, in view of their shape, 
the good chemical stability of PCL copolymers in water that undergo degradation at 
very slow rate and the envisioned good stability of the ester link between the nanotube 
and the diblock copolymer that is protected from the outer medium (e.g., acid gastric 
fluids) by the PCL coating, the hybrid core-shell materials described here were 
designed for ultimate use as a valuable delivery platform for non-parenteral in general 
and oral drug delivery in particular. Investigating the stability of the hybrid 
nanomaterials in gastrointestinal-like medium was beyond the scope of this work and 
will be studied in the future. Eventually, to prevent any hydrolysis due to the acid gastric 
medium and ensure full chemical stability, the nanoparticles could be encapsulated 
within a gastro-resistant capsule that disintegrates exclusively in the small intestine and 
thus, releases the cargo. In this context, next, we evaluated the cell compatibility of 
BNNT-OH and BNNT-PCL-b-PEG towards the Caco2 cell line, a standard model of 
the intestinal epithelium, for the first time.30,31 For this, we used the MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay.  The time for the assay 
(24 h) was chosen considering that in oral administration, the transit time is up to 6 h.32 
Good cell compatibility was observed at relatively low BNNT-OH and BNNT-PCL-b-
PEG concentration (5-10 µg/mL). Increasing the BNNT concentration resulted in a 
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slight (not statistically significant) decrease in cell viability (64-66% ) for 50 g/mL 
(Figure 3). Previous works reported on the good cell compatibility of BNNTs up to a 
concentration of 20 g/mL.33 In this sense, our findings are promising, especially 
considering the higher sensitivity of in vitro models with respect to in vivo ones.34 As 
the BNNT concentration reached 70 g/mL, the cytotoxicity of BNNT-OH increased 
significantly (viability < 40%). In contrast, the cell viability of BNNT-PCL-b-PEG 
remained similar (~65 %). This result is important as it demonstrates the outstanding 
contribution of the polymer shell in enhancing the cell compatibility of BNNTs. Assays 
utilizing more complex in vitro models of intestinal mucosa, such as comprising the co-
culture of Caco2 cells and mucin-secreting goblet cells, will be performed to ensure the 
effectiveness of the copolymer shell in increasing the compatibility of hybrid materials 
containing BNNTs and also assess mucoadhesion.            
 
 
 
 
 
 
 
 
 
 
Figure 3.  Caco2 cell viability. Cells were exposed to unmodified and modified 
BNNTs for 24 h and the viability estimated by MTT. *P <0.001 was considered 
statistically significant.  
 
To challenge the encapsulation performance of the BNNT-PCL-b-PEG materials 
described here, we used curcumin (CUR), a hydrophobic molecule of very low 
solubility in water (1 μg/mL). Curcumin is a natural polyphenol investigated as 
antioxidant, anti-inflammatory,35 and currently in Phase II clinical trials for the 
chemotherapy of prostate cancer.36 However, low aqueous solubility, fast degradation, 
and rapid clearance all together, severely limit the oral bioavailability of CUR, 
jeopardizing the development of pharmaceutical products, further clinical evaluations, 
and its eventual approval as drug.37–39 
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The underlining assumption in designing BNNT-PCL-b-PEG hybrid materials  was that 
the the hydrophobic PCL domains would act as reservoir for hydrophobic drugs, wich 
would strongly enhance drug loading efficiency.  To test this hypothesis, we compared 
the CUR loading efficiency of BNNT-PCL-b-PEGs with the loading efficiency of 
glycine-treated BNNTs,16 where CUR was loaded in the BNNTs inner channel under 
reduced pressure.  
Specifically, in a first step, we incorporated CUR inside the inner tube of  BNNT-PCL-
b-PEGs by using the capillary forces as described previously.  The  recovered material 
was washed profusely with acetone to remove excess CUR and dried . In a second step, 
CUR was incorporated into the PCL domains by the solvent evaporation method: the 
recovered powder was dispersed in water ; then, a CUR solution in acetone was added 
dropwise into the BNNTs aqueous dispersion. After acetone evaporation, the dispersion 
was subjected to centrifugation; the pellet was washed several times with water and 
then freeze-dried.40 The recovered dry powder was re-dispersed in ethanol and 
subjected to centrifugation. the the CUR concentration in the supernatant measured by 
UV spectrophotometry ( = 425 nm) employing a calibration curve in ethanol (see 
experimental section). The CUR load in the solid was 31.3% w/w (based on dry 
weight), representing a 313-fold increase in its apparent nanomaterial separated by 
centrifugation and solubility (in drug-loaded nanotubes dispersion of 1 mg/ml) with 
respect to the aqueous intrinsic solubility. These findings confirm the key role played 
by the PCL domain in hosting the hydrophobic cargo by allowing a 2.4-fold increase 
of the encapsulation capacity with respect to the glycine-coated BNNTs.16 This 
performance is unprecedented for the encapsulation of hydrophobic molecules by 
BNNTs and represents an important improvement, compared to standard polymeric 
micelles. Next, we will investigate other boron nitride derivatives with different 
microstructure and morphology and their interactions with relevant biological systems.   
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